Overview Accelerating Clinical Trials Evaluating Disease-Modifying Therapies For T1D Letters of intent (LOI’s) are sought from academic and/or industry applicants for clinical trials to evaluate drugs and biologics to delay, halt, or reverse T1D through suppor…